1' -substituted carba-nucleoside analogs for antiviral treatment

Details for Australian Patent Application No. 2009240642 (hide)

Owner Gilead Sciences, Inc.

Inventors Saunders, Oliver L.; Zhang, Lijun; Butler, Thomas; Kim, Choung U.; Cho, Aesop; Parrish, Jay

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009240642

PCT Pub. Number WO2009/132135

Priority 61/047,263 23.04.08 US; 61/139,449 19.12.08 US

Filing date 22 April 2009

Wipo publication date 29 October 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4188 (2006.01)

A61K 31/7052 (2006.01)

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07H 19/23 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

11 November 2010 PCT application entered the National Phase

  PCT publication WO2009/132135 Priority application(s): WO2009/132135

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009240643-Carboxamide compounds for the treatment of metabolic disorders

2009240640-Interference management with reduce interference requests and interference indicators